FZD2 and ovarian serous adenocarcinoma: ALPL might restrict the function of the WNT5A–FZD2–STAT3 axis, a non-canonical WNT pathway promoting epithelial-mesenchymal transition progression, which results in attenuated migration and invasion in high grade serous ovarian cancer cells and improves survival in patients with serous ovarian cancer (52).